EUVIMEDEUVIMED entdecken
Crossref

Blood plasma adipomyokine levels and proteinaseinhibitory activity in sarcopenic obesity

Liudmila V. Spirina, Valeria A. Shokalo, Olga E. Akbasheva, Denis A. Dyakov, Lyudmila M. Shuliko, Dmitry A. Svarovsky, Iulia G. Samoilova, Maria V. Matveeva, Jude I. Ogieuhi, Diana L. Shilova

Kazan medical journal · 28.07.2026 · 107 (4) · 528-544

DOI: 10.17816/kmj690265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kazan medical journal, online erschienen am 28.07.2026. Verfasst von Liudmila V. Spirina und 9 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The search for diagnostic markers reflecting muscle function, protein catabolism, and adipose tissue metabolism in sarcopenia is an important medical problem. AIM: To assess the levels of asprosin (adipokine), meteorinlike protein (myokine), and proteinaseinhibitory activity in blood plasma, and their relationship with metabolic parameters and sarcopenia criteria in sarcopenic obesity and during the presarcopenic phase. METHODS: The study included 50 participants (38 women, 12 men) aged 45–85 years. Of these, 11 had sarcopenia (reduced strength and mass), 16 had presarcopenia (reduced strength), and 23 served as controls (no strength or mass loss). We measured asprosin, meteorinlike protein, elastase and trypsinlike proteinase activity, and alpha1proteinase inhibitor in plasma. RESULTS: In sarcopenic obesity, asprosin correlated positively with fat mass (rs = 0.73, p = 0.012) and negatively with muscle strength (rs = −0.81, p = 0.023). Asprosin was higher in sarcopenia without obesity than in sarcopenic obesity: 9.200 (8.500; 9.300) vs 7.100 (6.000; 7.900) ng/mL (p = 0.045). Meteorinlike protein exceeded the upper reference limit (179–1990 pg/mL) in 50% of controls (up to 2191–2871 pg/mL) and 25% of presarcopenic participants (up to 2275–4647 pg/mL). In sarcopenic obesity, meteorinlike protein correlated negatively with Cpeptide (rs = −0.74, p = 0.005) and HOMAIR (rs = −0.79, p = 0.011). In controls, meteorinlike protein was lower in hypertensive participants, while both meteorinlike protein and asprosin were lower in type 2 diabetes. Proteinaseinhibitor imbalance in presarcopenia included increased trypsinlike activity (1.5fold) and decreased elastaselike activity (23%). Trypsinlike activity correlated with SARCF score (rs = 0.69, p = 0.02) and reduced performance. Higher alpha1proteinase inhibitor was associated with lower strength (rs = −0.62, p = 0.03) and muscle mass (rs = −0.63, p = 0.04) in controls, and with slower gait speed (rs = −0.9, p = 0.02) in presarcopenic obese participants. CONCLUSION: Adipomyokine dysfunction and plasma proteinaseinhibitor imbalance, combined with metabolic disturbances, may play a role in the development of sarcopenic obesity.

Zitieren

APA

Spirina, L. V., Shokalo, V. A., Akbasheva, O. E., Dyakov, D. A., Shuliko, L. M., Svarovsky, D. A., Samoilova, I. G., Matveeva, M. V., Ogieuhi, J. I., & Shilova, D. L. (2026). Blood plasma adipomyokine levels and proteinaseinhibitory activity in sarcopenic obesity. Kazan medical journal, 107(4), 528-544. https://doi.org/10.17816/kmj690265

Vancouver

Spirina LV, Shokalo VA, Akbasheva OE, Dyakov DA, Shuliko LM, Svarovsky DA, et al. Blood plasma adipomyokine levels and proteinaseinhibitory activity in sarcopenic obesity. Kazan medical journal. 2026;107(4):528-544. doi:10.17816/kmj690265

BibTeX
@article{Spirina2026,
  author = {Spirina, Liudmila V. and Shokalo, Valeria A. and Akbasheva, Olga E. and Dyakov, Denis A. and Shuliko, Lyudmila M. and Svarovsky, Dmitry A. and Samoilova, Iulia G. and Matveeva, Maria V. and Ogieuhi, Jude I. and Shilova, Diana L.},
  title = {Blood plasma adipomyokine levels and proteinaseinhibitory activity in sarcopenic obesity},
  journal = {Kazan medical journal},
  year = {2026},
  volume = {107},
  number = {4},
  pages = {528--544},
  doi = {10.17816/kmj690265}
}
Kostenlos starten →